These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 37936299

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa.
    Paller AS, Guide SV, Ayala D, Gonzalez ME, Lucky AW, Bagci IS, Marinkovich MP.
    J Dermatolog Treat; 2024 Dec; 35(1):2350232. PubMed ID: 38724041
    [Abstract] [Full Text] [Related]

  • 3. Beremagene Geperpavec: First Approval.
    Dhillon S.
    Drugs; 2023 Aug; 83(12):1131-1135. PubMed ID: 37432558
    [Abstract] [Full Text] [Related]

  • 4. Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB).
    Epstein AL, Haag-Molkenteller C.
    Cell; 2023 Aug 17; 186(17):3523-3523.e1. PubMed ID: 37595560
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
    Subramaniam KS, Antoniou MN, McGrath JA, Lwin SM.
    Br J Dermatol; 2022 Apr 17; 186(4):609-619. PubMed ID: 34862606
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey.
    Fulchand S, Harris N, Li S, Barriga M, Gorell E, De Souza M, Murrell D, Marinkovich MP, Krishna Yenamandra V, Tang JY.
    Pediatr Dermatol; 2021 Sep 17; 38(5):1198-1201. PubMed ID: 34515355
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gene therapy for recessive dystrophic epidermolysis bullosa.
    Titeux M, Pendaries V, Hovnanian A.
    Dermatol Clin; 2010 Apr 17; 28(2):361-6, xii. PubMed ID: 20447504
    [Abstract] [Full Text] [Related]

  • 17. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
    Eichstadt S, Barriga M, Ponakala A, Teng C, Nguyen NT, Siprashvili Z, Nazaroff J, Gorell ES, Chiou AS, Taylor L, Khuu P, Keene DR, Rieger K, Khosla RK, Furukawa LK, Lorenz HP, Marinkovich MP, Tang JY.
    JCI Insight; 2019 Oct 03; 4(19):. PubMed ID: 31578311
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.